GlassScriptPhysician profile
Ashley M Martin
NPI 1063194009
$1,083.99
in general payments reported to CMS, 2019-2025
12 companies · $195 in 2025
The $195 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $158 · 2024: $731 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $984 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $984.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $256.87 | 2024 | Austedo Xr |
| Supernus Pharmaceuticals, INC. | $188.51 | 2023-2025 | Qelbree, Qelbree |
| Gilead Sciences, INC. | $133.35 | 2025 | Epclusa |
| Abbvie INC. | $130.05 | 2023-2024 | |
| Neurocrine Biosciences, INC. | $121.94 | 2024 | Ingrezza |
| Medtronic, INC. | $104.00 | 2024 | Linq II |
| Janssen Pharmaceuticals, INC | $51.03 | 2024 | Spravato |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $23.35 | 2023 | |
| Geron Corporation | $21.04 | 2025 | Rytelo |
| Abiomed | $20.97 | 2023 | Impella |
| Otsuka America Pharmaceutical, INC. | $19.84 | 2025 | Rexulti |
| Idorsia Pharmaceuticals US INC | $13.04 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.